Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: A placebo-controlled randomized trial

European Journal of Clinical Investigation

Volumn 40, Issue 2, 2010, Pages 148-154

  Heinisch, B B ^a   Francesconi, M ^b   Mittermayer, F ^a   Schaller, G ^a   Gouya, G ^a   Wolzt, M ^a   Pleiner, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Rehabilitationszentrum Alland ^*  (Austria)

Author keywords

Acetylcholine; Alpha lipoic acid; Forearm blood flow; Glycerol trinitrate; Type 2 diabetes

Indexed keywords

ACETYLCHOLINE; ALLOPURINOL; FIBRIC ACID DERIVATIVE; FOLIC ACID; GABAPENTIN; GLITAZONE DERIVATIVE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NICERGOLINE; PROTON PUMP INHIBITOR; SULFONYLUREA; THIOCTIC ACID;

ADULT; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOREARM BLOOD FLOW; HUMAN; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; REGIONAL BLOOD FLOW; THIOCTIC ACID; VASODILATION; VASODILATOR AGENTS;

EID: 75149165328     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02236.x     Document Type: Article

References (31)

1. Clark CM Jr., Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995 332 : 1210 1217.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 339 : 229 234.
3. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996 97 : 2601 2610.
4. Baron AD. Insulin resistance and vascular function. J Diabetes Complications 2002 16 : 92 102.
5. Moncada S, Herman AG, Vanhoutte PM. Endothelium-derived relaxing factor is identified as nitric oxide. Trends Pharmacol Sci 1987 8 : 365 368.
6. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989 3 : 2007 2018.
7. Suzuki YJ, Tsuchiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 1991 15 : 255 263.
8. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995 19 : 227 250.
9. Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H et al. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 1999 26 : 1495 1500.
10. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschutter A, Meinertz T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001 31 : 53 61.
11. Hokanson DE, Sumner DS, Strandness DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975 22 : 21 4.
12. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995 25 : 918 923.
13. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002 106 : 1460 1464.
14. Pleiner J, Wolzt M. Assessment of vascular function. In : Roden M, editors. Clinical Diabetes Research: Methods and Techniques. Chichester, England : John Wiley & Sons Ltd 2007: pp 289-310.
15. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999 22 : 1296 1301.
16. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986 39 : 489 490.
17. Du X, Stocklauser-Farber K, Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med 1999 27 : 752 763.
18. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997 46 : 1481 1490.
19. Stevens MJ, Obrosova X, Cao X, van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 2000 49 : 1006 1015.
20. Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia 1999 42 : 343 350.
21. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant a-lipoic acid. Free Radic Biol Med 1997 22 : 359 378.
22. Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol (Oxf) 2008 68 : 716 723.
23. Harris RA, Nishiyama SK, Wray DW, Tedjasaputra V, Bailey DM, Richardson RS. The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia. Eur J Appl Physiol 2009 107 : 445 453.
24. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009 1790 : 1149 1160.
25. Smith AR, Visioli F, Frei B, Hagen TM. Lipoic acid significantly restores, in rats, the age-related decline in vasomotion. Br J Pharmacol 2008 153 : 1615 1622.
26. Artwohl M, Muth K, Kosulin K, de Martin R, Hölzenbein T, Rainer G et al. R-(+)-alpha-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1. Am J Physiol Endocrinol Metab 2007 293 : E681 9.
27. Sabharwal AK, May JM. Alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. Mol Cell Biochem 2008 309 : 125 132.
28. Gianturco V, Bellomo A, D'Ottavio E, Formosa V, Iori A, Mancinella M et al. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 2009 49 : S129 33.
29. Teichert J, Kern J, Tritschler HJ, Ulrich H, Preiss R. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 1998 36 : 625 628.
30. Preiss R, Teichert J, Preiss C, Kern J, Tritzschler HJ, Ulrich H. Untersuchungen zur Pharmakokinetik von alpha-Liponsäure (Thioctsäure) an Patienten mit diabetischer Polyneuropathie. Diabetes und Stoffwechsel 1996 5 : 17 22. (Pubitemid 27083406)
31. Vossler S, Füllert S, Schneider F, Haak E, Haak T, Samigullin R et al. Pharmacodynamic effects of orally administered dexlipotam on endothelial function in type 2-diabetic patients. Int J Clin Pharmacol Ther 2007 45 : 385 393.